Amelita Galli-Curci was one of the first female operatic stars of the phonograph. Compton Mackenzie, the founder of The Gramophon magazine said he could accept old age if he had as many records of Galli-Curci as of Caruso. Her background was Italian and Spanish. Born Amelita Galli, she was a piano student in a well-to do musical household. The well-known opera composer Mascagni visited her parents and on hearing her play and sing recommended that she become a singer. After that, Amelita diligently taught herself. She made her debut in 1906 as Gilda in Rigoletto, which remained a favorite role, and she took about ten years - a pretty typical amount of time - to become a star. She married the Marchese di Sineri and added his family name of Curci to her own. On her birthday in 1916 she scored a major triumph in Chicago that made her an international star.
She had a fluid, clear, very beautiful voice and a great gift for sustaining lyric lines. She was at her best in roles calling for grace, pathos, and happiness and had neither the stage temperament nor the dramatic style needed for fiery, tempestuous parts. Her voice recorded very well, particularly in the acoustic process, where it was taken down with such clarity and resonance that listeners supposed it was a large-sounding voice, which it was not, in person. The adjective that live listeners used frequently for her voice was "celestial." Her range at her peak was to the E above high C. She is said to have lacked stage presence.
During the last days of the acoustic recording era (around 1924) musicians began to notice a curious lack of precision in intonation above the note F. At the same time, the top notes of her range began to lose their penetration. This began to be noticed at the same time the shift to electrical recording took place. In 1935 it was discovered that she had a goiter, a form of throat tumor that had progressively been closing off the flow of her breath. It was surgically removed, but she never recovered her vocal powers. ~ Joseph Stevenson
© 2014 Rovi Corporation.